Ask HopeStage to review this study with me
Study ID: NCT01495156. We help you review the study, but cannot decide medical eligibility.
WithdrawnNCT01495156
the Efficacy of Adjunctive Lithium Treatment for Psychotic Mania
This study has public registry information. It focuses on bipolarity and currently lists study information in the United States.
Bipolarity, SchizophreniaDrugFrom 12 Years to 18 Years
Key information made simple
What is this study testing?
This study is testing whether the Efficacy of Adjunctive Lithium Treatment may be useful for people experiencing bipolarity.
What would participation involve?
Participants may receive the Efficacy of Adjunctive Lithium Treatment, attend study visits with the research team. The registry lists locations in the United States.
Who is it mainly for?
This study appears to be mainly for people with bipolarity. Because it may involve minors, a parent or guardian may need to be involved.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, what role parents or guardians have in the process.
Your next step
The official record suggests in-person participation through a hospital, with sites including The Zucker Hillside Hospital, North Shore-LIJ Health System in Glen Oaks. Participation appears to involve guided sessions or support activities with check-ins on how they fit into daily life. The main fit is usually matching the main diagnosis and meeting the main study requirements, while common reasons not to take part include safety concerns that need urgent care first and pregnancy or breastfeeding. This is a later-stage study, which usually means the approach is being followed in broader real-world use.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
Study start dateSeptember 2011
- Recruitment status
- Withdrawn
- Estimated enrollment
- Not clearly listed
- Sponsor
- Northwell Health
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 12 Years to 18 Years
- Official registry ID
- NCT01495156
- Official title
- Study of the Efficacy of Adjunctive Lithium Treatment for the Treatment of Psychotic Mania
- Official source
- Official registry link
Want help reviewing this study?
Study ID: NCT01495156. We help you review the study, but cannot decide medical eligibility.
For you
Taking part may give access to a new approach being evaluated.
It requires regular visits and structured follow-up.
Requires travel, with in-person participation in United States.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with bipolarity. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study. The phase is not clearly listed in the public registry. Phase is mostly relevant for medication studies and some device studies. For this study, it may be more useful to look at what is required, the duration, visits, and eligibility criteria.
Who might this study be for?
This study may concern people with bipolarity; age range: From 12 Years to 18 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Northwell Health, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The registry indicates that this study is not currently recruiting. Check the official registry for the reason and latest status.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
WithdrawnNCT04054973
L-arginine Study for Persistent Symptoms of Schizophrenia
This study has public registry information. It focuses on schizophrenia and currently lists study information in the United States.
WithdrawnNCT00512616
A Glutamate Transporter GLT1, in the Treatment of Bipolarity
This study has public registry information. It focuses on bipolarity and currently lists study information in the United States.
WithdrawnNCT04211428
A Non-Interventional Study to Explore the Role of Gut Flora in Bipolarity
This study has public registry information. It focuses on bipolarity and currently lists study information in the United States.